Organogenesis Holdings (ORGO) Selling, General & Administrative (2017 - 2026)
Organogenesis Holdings (ORGO) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Organogenesis Holdings | 239.33 Mn | 192.49 Mn | 20.08 Mn | 53.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.97 Mn |
| Mar 31, 2026 | 65.19 Mn |
| Dec 31, 2025 | 100.17 Mn |
| Sep 30, 2025 | 79.74 Mn |
| Jun 30, 2025 | 73.81 Mn |
| Mar 31, 2025 | 72.51 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 71.80 Mn |
| Jun 30, 2024 | 76.54 Mn |
| Mar 31, 2024 | 72.32 Mn |
| Dec 31, 2023 | 61.38 Mn |
| Sep 30, 2023 | 64.22 Mn |
| Jun 30, 2023 | 70.32 Mn |
| Mar 31, 2023 | 73.83 Mn |
| Dec 31, 2022 | 68.29 Mn |
| Sep 30, 2022 | 79.33 Mn |
| Jun 30, 2022 | 72.61 Mn |
| Mar 31, 2022 | 63.58 Mn |
| Dec 31, 2021 | 67.25 Mn |
| Sep 30, 2021 | 62.37 Mn |